Exhibitor Product Theaters

Open to all Virtual ACG 2020 attendees, these sponsored presentations provide additional educational opportunities for attendees. No CME is provided for Theater presentations. These programs are listed in the Sessions section of the virtual platform. To register, add the program to your schedule within the virtual platform. All times are listed as Eastern Time.


Seeing Results Clearly in Crohn’s Disease

Asher Kornbluth, MD
1:00 pm – 2:00 pm
Join us to learn about a treatment for patients with moderate to severe Crohn’s Disease.
This event is sponsored by AbbVie.


Understanding a Treatment Journey for Patients With Short Bowel Syndrome: A Clinical Perspective on the Potential Role of GATTEX® (teduglutide) in Adult Patients With SBS

Robert Carroll, MD
1:00 pm – 2:00 pm
Short bowel syndrome (SBS) is a serious and chronic malabsorption disorder resulting from physical loss and functional deficiency of portions of the intestine, primarily due to surgical resection. This program will discuss the role of GATTEX in patients with SBS and will highlight a patient case study.
Sponsored by Takeda Pharmaceuticals U.S.A., Inc.


Treatments for the Active Management of IBS‐C, CIC and IBS‐D
Featuring Telemedicine and Phase 3B Data for a Treatment Option for IBS‐C

Darren M. Brenner, MD, FACG
2:00 pm – 3:00 pm
IBS‐C, CIC and IBS‐D are prevalent disorders with chronic and burdensome symptoms that impact many adult Americans. Currently, only a fraction of those experiencing symptoms actually seek care with their HCP, which leaves many untreated and still suffering. Please join us for a virtual product theater with Dr. Darren Brenner to review clinical data on treatments that may help your patients.
This program is sponsored by AbbVie and Ironwood.

Investigating the Potential of Immuno-Oncology Research

Speaker TBD
4:30 pm – 5:30 pm
Immuno-Oncology (I-O) research is the investigation of innovative approaches that aim to harness the body’s natural immune response to fight cancer. BMS offers an unbranded educational speaker program; the goal of this program is to increase awareness of the potential of I-O research.
This expert theater is sponsored by Bristol Myers Squibb.

Jumping JAK-STAT: Translating Science to Understanding Disease – the JAK-STAT Pathway in IBD

Florian Rieder, MD, FACG
5:30 pm – 6:30 pm
This program will provide education on the JAK-STAT pathways by reviewing how different cytokines influence cellular mechanisms and modulate gene transcription. The aberrant cytokine signals mediated by JAK-STAT pathways, play a key role in the pathogenesis of IBD.
This Exhibitor Program is sponsored by Gilead Sciences, Inc.


Seeing The Unseen - Identifying Exocrine Pancreatic Insufficiency in Chronic Pancreatitis

Tyler Stevens, MD, MS, FACG
2:00 pm – 3:00 pm
This product theater, sponsored by AbbVie, is designed to help medical professionals recognize exocrine pancreatic insufficiency (EPI) in patients with chronic pancreatitis. Throughout this program, we will review the symptoms and clinical consequences of EPI and provide insights on how to diagnosis EPI through the use of supplemental laboratory tests.
This program is sponsored by AbbVie.

Hear a Leading Expert Discuss a Treatment for Moderate to Severe Crohn's Disease (CD)

Asher Kornbluth, MD
4:30 pm – 5:30 pm
This program is sponsored by Takeda Pharmaceuticals U.S.A., Inc.

Learn about Motegrity (prucalopride), a treatment option introduced in 2019

Brooks D. Cash, MD, FACG
5:30 pm – 6:30 pm
This speaker program will discuss an approved treatment option, Motegrity. Hear Dr. Brooks D. Cash explain and answer questions about clinical trial design, mechanism of action, safety and efficacy data, and dosing/administration information for Motegrity.
This event is sponsored by Takeda Pharmaceuticals U.S.A., Inc.


See EoE: A Closer Look at Diagnosing and Managing Eosinophilic Esophagitis

Ikuo Hirano, MD, FACG, Jonathan Spergel, MD, PhD
2:00 pm – 3:00 pm
Join our multidisciplinary speakers as they walk us through their perspectives of the most recent diagnostic and management guidelines for Eosinophilic Esophagitis. Together they will define EoE, describe various manifestations of chronic esophageal inflammation, and explore diagnostic challenges and management approaches in the context of guideline recommendations.
This event is sponsored by Takeda Pharmaceuticals U.S.A., Inc.

Understanding the Data on Exocrine Pancreatic Insufficiency (EPI)

Douglas G. Adler, MD, FACG
4:30 pm – 5:30 pm
This event is sponsored by AbbVie.